Return to site

Treate hepatitis c infection with LEDIPASVIR AND SOFOSBUVIR

· Hepatitis C
Ledipasvir and sofosbuvir

Ledipasvir and sofosbuvir are used together in the treatment of chronic hepatitis C virus (HCV) infection. The fixed-dose combo of LEDIPASVIR & SOFOSBUVIR is an effectual way of treating chronic hepatitis C (HCV) infection of genotypes 1, 4, 5 and 6.

Ribavirin, also referred to as tribavirin, is an important antiviral medication for treating HCV. For HCV patients with genotype 1A and not having a cirrhotic liver, Ledipasvir & Sofosbuvir is used without ribavirin.

Ledipasvir & Sofosbuvir was the first FDA-approved interferon and ribavirin-free regimen for treating hepatitis C. Furthermore, the duo is a direct-acting antiviral regimen.


HCV NS5A is a viral phosphoprotein. It plays the key role in viral assembly, replication and secretion. Ledipasvir acts as a potent inhibitor of HCV NS5A.


Hepatitis C Virus NS5B polymerase is the key enzyme responsible for mediating HCV RNA replication. Sofosbuvir is a nucleotide analog inhibitor of HCV NS5B.

In its triphosphate form, sofosbuvir imitates the natural cellular uridine nucleotide. Hence, it is assimilated by the HCV RNA polymerase, NS5B, into the extending RNA primer strand. This ultimately leads to a viral chain termination.


Both Ledipasvir and sofosbuvir are antiviral medications. Both of these medications work by lessening the amount of hepatitis C virus in the body.

These medications achieve so by eliminating the hepatitis C virus gradually from the blood. The specific period of time required for doing so depends on the intensity of the HCV infection.


Typically, dosage for the Ledipasvir & Sofosbuvir in treating HCV infection is limited to single-pill for a single-day. Nonetheless, this might vary in some cases.


Several clinical trials and observational studies define the effectiveness of the Ledipasvir & Sofosbuvir combination in fighting HCV. In most of them, the duo has proved to provide 12-week results of other popular HCV treatments in just an 8-week regimen.

Side Effects

When overdosed, Ledipasvir and sofosbuvir are known to cause two health issues, which are

  • Tiredness – An overdose of LEDIPASVIR & SOFOSBUVIR might result in severe tiredness in the body.
  • Headache – A severe headache might also result due to an overdosing of LEDIPASVIR & SOFOSBUVIR.


Ledipasvir & Sofosbuvir falls into the same level of safety as that of the Sofosbuvir-Velpatasvir, another NS5B-NS5A inhibitor duo.


Here are some of the popular LEDIPASVIR & SOFOSBUVIR medicines available in the market:

  • Cimivir L
  • Hepcinat-LP
  • Hepcvir L
  • Ledifos
  • Ledihep
  • Ledviclear
  • Resof-L
  • Sofab LP
  • Sofocruz LP
  • Sofokem L

How To Order Medicines

To buy LEDIPASVIR & SOFOSBUVIR Medicines in Russia, China, Philippines, US fill out the form on the website at Our team will contact you after filling out the form to discuss the details of the purchase. You can also contact us by phone: + 91-9999098733 , by e-mail or you can directly visit our site

All Posts

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly